Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jun 01, 2007 (Vol. 27, No. 11)

Phyloinformatics.org

URL:www.phyloinformatics.org
  • Biological history
  • Lack of significant content
There must be something about this site that I don’t understand. What I do understand is this. The name ‘Phyloinformatics’ suggests an uber site for phylogenetic information, at least to me. At the Phyloinformatics site, the opening page has a long but well-written description entitled ‘Biology’. Surrounding this article are Google Ads on the left and top of the page, though at first glance they appear to be interesting links. On the right side of the page are a set of links to topics ranging from Xbox 360 to Music CDs to Software. That’s all there is to the site, as best I can see. What I don’t understand is 1) what the title has to do with the site and 2) how the site rates advertisements if the main thing it offers is a long-winded description of biology. The Google Ads actually are useful links and would otherwise be interesting connections for a site like this. Why Google advertises here, though is puzzling.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »